Bone Conduction Implant (BCI)
OtherImprovement in hearing using BCI.
NCT Number: NCT06634784
This study, titled "The BONEBRIDGE in Children Under Five: Premarket Clinical Investigation" (Study ID 2023BB006), looks at kids under five who have received the BONEBRIDGE BCI 602 hearing implant. This observational study, which is both retrospective (looking back) and prospective (looking forward), will take place at multiple hospitals. The main goal is to see if the BONEBRIDGE implant is safe for young children within 12 months after surgery.
Primary Goal: The study's main aim is to collect all information about any bad experiences or issues related to the device and the surgery to check its safety.
Secondary Goals:
Hearing Improvement: Using tests like the Göttinger Speech Intelligibility Test (Word Recognition Scores) to see how much the hearing improves with the implant.
Treatment History: Surgeons will fill out questionnaires about how the treatment went.
Quality of Life: Parents will answer questions about their child's quality of life using the GCBI questionnaire at least 12 months after the implant.
The study will last up to 12 months, including enrolling participants and performing all necessary procedures. The target number of participants includes at least 12 sets of data for safety checks and at least 5 sets of hearing performance data.
By collecting detailed information on any problems and assessing the performance of the BONEBRIDGE implant, this study aims to determine if it is safe and effective for young children.
Looking for future studies?
Notify Me1 year–9 year
All sexes
Observational
Medizinische Hochschule Hannover, Hanover, Lower Saxony, Germany
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Children who received the BONEBRIDGE BCI 602 implant before the age of five and have had the implant for at least 12 months.
Ability to perform the German language test. Willingness and ability to undergo all tests required by the study. Signed and dated informed consent obtained before any study-specific procedure and collection of retrospective data.
Exclusion criteria
Inability to perform audiological tests due to psychological, emotional, or related physical disorders.
Failure to meet any inclusion criteria. Any condition that, in the investigator's opinion, poses an increased risk to the patient or prevents full compliance or completion of the study.
Improvement in hearing using BCI.
Time frame: Day 1
Hearing Improvement: determined by using the Göttinger Speech Intelligibility Test (Word Recognition Scores). Improvements in hearing with the BONEBRIDGE implant will be evaluated in device aided and unaided condition at least 12 months post-implantation.
Time frame: Day 1
Quality of life questionnaires (GCBI) for parents at least 12 months post-implantation.
Time frame: Day 1
Surgeons will complete questionnaires about the treatment history.
MED-EL Elektromedizinische Geräte GesmbH
Industry
The BONEBRIDGE in Children Below Five Years of Age Premarket Clinical Investigation
Acronym: 2023BB006
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07156461
Bone Conduction, Ear Diseases
Denver, Colorado, United States
View Trial DetailsNCT04761926
Ear Diseases, Hearing Disorders
Aalborg, Denmark
View Trial DetailsNCT04427033
Ear Diseases, Hearing Disorders
Innsbruck, Austria
View Trial DetailsNCT05086809
Deafness, Ear Diseases
Copenhagen, Smørum, Denmark
View Trial Details